wausaupilotandreview.com
Johnson & Johnson hit with record $4.69B loss in ovarian cancer case
By Myron Levin and Stuart Silverstein Fair Warning The legal assault on Johnson & Johnson and its signature baby powder reached new heights this week,
Shereen Siewert